These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2972779)

  • 1. Direct evidence for the clustered nature of complement receptors type 1 on the erythrocyte membrane.
    Paccaud JP; Carpentier JL; Schifferli JA
    J Immunol; 1988 Dec; 141(11):3889-94. PubMed ID: 2972779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution in clusters of complement receptor type one (CR1) on human erythrocytes.
    Chevalier J; Kazatchkine MD
    J Immunol; 1989 Mar; 142(6):2031-6. PubMed ID: 2522131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Difference in the clustering of complement receptor type 1 (CR1) on polymorphonuclear leukocytes and erythrocytes: effect on immune adherence.
    Paccaud JP; Carpentier JL; Schifferli JA
    Eur J Immunol; 1990 Feb; 20(2):283-9. PubMed ID: 2138082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the baboon erythrocyte C3b-binding protein.
    Birmingham DJ; Cosio FG
    J Immunol; 1989 May; 142(9):3140-4. PubMed ID: 2523426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune complex binding efficiency of erythrocyte complement receptor 1 (CR1).
    Madi N; Paccaud JP; Steiger G; Schifferli JA
    Clin Exp Immunol; 1991 Apr; 84(1):9-15. PubMed ID: 1826650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
    Ross GD; Yount WJ; Walport MJ; Winfield JB; Parker CJ; Fuller CR; Taylor RP; Myones BL; Lachmann PJ
    J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies to mouse complement receptor type 1 (CR1). Their use in a distribution study showing that mouse erythrocytes and platelets are CR1-negative.
    Kinoshita T; Takeda J; Hong K; Kozono H; Sakai H; Inoue K
    J Immunol; 1988 May; 140(9):3066-72. PubMed ID: 2966205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of model immune complexes to erythrocyte CR1 facilitates immune complex uptake by U937 cells.
    Emlen W; Burdick G; Carl V; Lachmann PJ
    J Immunol; 1989 Jun; 142(12):4366-71. PubMed ID: 2524529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal function of CR1 on affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria.
    Roberts WN; Wilson JG; Wong W; Jenkins DE; Fearon DT; Austen KF; Nicholson-Weller A
    J Immunol; 1985 Jan; 134(1):512-7. PubMed ID: 2578050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Erythrocyte CR1 receptor: binding and transport of immune complexes in the blood circulation].
    Pascual M; Schifferli JA
    Schweiz Med Wochenschr; 1993 Jan; 123(3):39-43. PubMed ID: 8426946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for distinct intracellular pools of receptors for C3b and C3bi in human neutrophils.
    O'Shea JJ; Brown EJ; Seligmann BE; Metcalf JA; Frank MM; Gallin JI
    J Immunol; 1985 Apr; 134(4):2580-7. PubMed ID: 3156186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of hypocomplementaemia and low erythrocyte complement receptor type 1 numbers in determining abnormal immune complex clearance in humans.
    Schifferli JA; Ng YC; Paccaud JP; Walport MJ
    Clin Exp Immunol; 1989 Mar; 75(3):329-35. PubMed ID: 2522842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune complexes bind preferentially to specific subpopulations of human erythrocytes.
    Cosio FG; Shen XP; Hebert LA
    Clin Immunol Immunopathol; 1990 Jun; 55(3):337-54. PubMed ID: 2140304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of vesicles enriched in complement receptor 1 from human erythrocytes.
    Pascual M; Lutz HU; Steiger G; Stammler P; Schifferli JA
    J Immunol; 1993 Jul; 151(1):397-404. PubMed ID: 8326133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative analyses of the binding of soluble complement-fixing antibody/dsDNA immune complexes to CR1 on human red blood cells.
    Edberg JC; Wright E; Taylor RP
    J Immunol; 1987 Dec; 139(11):3739-47. PubMed ID: 2960742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of specific binding sites on Candida with functional and antigenic characteristics of human complement receptors.
    Edwards JE; Gaither TA; O'Shea JJ; Rotrosen D; Lawley TJ; Wright SA; Frank MM; Green I
    J Immunol; 1986 Dec; 137(11):3577-83. PubMed ID: 2946764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assay of membrane complement receptors (CR1 and CR2) with C3b- and C3d-coated fluorescent microspheres.
    Lambris JD; Ross GD
    J Immunol; 1982 Jan; 128(1):186-9. PubMed ID: 7033372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune complexes and erythrocyte CR1 (complement receptor type 1): effect of CR1 numbers on binding and release reactions.
    Ng YC; Schifferli JA; Walport MJ
    Clin Exp Immunol; 1988 Mar; 71(3):481-5. PubMed ID: 2968204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal immune adherence and elimination of hepatitis B surface antigen/antibody complexes in patients with AIDS.
    Madi N; Steiger G; Estreicher J; Schifferli JA
    J Immunol; 1992 Feb; 148(3):723-8. PubMed ID: 1530955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of human erythrocyte blood group antigens on the C3b/C4b receptor.
    Rao N; Ferguson DJ; Lee SF; Telen MJ
    J Immunol; 1991 May; 146(10):3502-7. PubMed ID: 1827486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.